BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 27772735)

  • 1. Retinal imaging and axonal degeneration in later onset multiple sclerosis.
    Huhn K; Lämmer R; Zimmermann H; Lämmer A; Waschbisch A; Utz K; Gieß RM; Paul F; Linker RA; Lee DH
    J Neurol Sci; 2016 Nov; 370():1-6. PubMed ID: 27772735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optical coherence tomography segmentation analysis in relapsing remitting versus progressive multiple sclerosis.
    Behbehani R; Abu Al-Hassan A; Al-Salahat A; Sriraman D; Oakley JD; Alroughani R
    PLoS One; 2017; 12(2):e0172120. PubMed ID: 28192539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of retinal atrophy in multiple sclerosis: A longitudinal study using spectral domain optical coherence tomography with segmentation analysis.
    Behbehani R; Adnan H; Al-Hassan AA; Al-Salahat A; Alroughani R
    Mult Scler Relat Disord; 2018 Apr; 21():56-62. PubMed ID: 29459346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optical Coherence Tomography Reveals Distinct Patterns of Retinal Damage in Neuromyelitis Optica and Multiple Sclerosis.
    Schneider E; Zimmermann H; Oberwahrenbrock T; Kaufhold F; Kadas EM; Petzold A; Bilger F; Borisow N; Jarius S; Wildemann B; Ruprecht K; Brandt AU; Paul F
    PLoS One; 2013; 8(6):e66151. PubMed ID: 23805202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis.
    Petzold A; Balcer LJ; Calabresi PA; Costello F; Frohman TC; Frohman EM; Martinez-Lapiscina EH; Green AJ; Kardon R; Outteryck O; Paul F; Schippling S; Vermersch P; Villoslada P; Balk LJ;
    Lancet Neurol; 2017 Oct; 16(10):797-812. PubMed ID: 28920886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness.
    Saidha S; Syc SB; Durbin MK; Eckstein C; Oakley JD; Meyer SA; Conger A; Frohman TC; Newsome S; Ratchford JN; Frohman EM; Calabresi PA
    Mult Scler; 2011 Dec; 17(12):1449-63. PubMed ID: 21865411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optical coherence tomography in patients with a history of juvenile multiple sclerosis reveals early retinal damage.
    Huhn K; Lämmer R; Oberwahrenbrock T; Lämmer A; Waschbisch A; Gosar D; Brandt A; Paul F; Linker RA; Lee DH
    Eur J Neurol; 2015 Jan; 22(1):86-92. PubMed ID: 25104178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal layer segmentation in patients with multiple sclerosis using spectral domain optical coherence tomography.
    Garcia-Martin E; Polo V; Larrosa JM; Marques ML; Herrero R; Martin J; Ara JR; Fernandez J; Pablo LE
    Ophthalmology; 2014 Feb; 121(2):573-9. PubMed ID: 24268855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Serum Neurofilament Light Chain With Inner Retinal Layer Thinning in Multiple Sclerosis.
    Sotirchos ES; Vasileiou ES; Filippatou AG; Fitzgerald KC; Smith MD; Lord HN; Kalaitzidis G; Lambe J; Duval A; Prince JL; Mowry EM; Saidha S; Calabresi PA
    Neurology; 2022 Aug; 99(7):e688-e697. PubMed ID: 35618438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inner Retinal Layer Changes Reflect Changes in Ambulation Score in Patients with Primary Progressive Multiple Sclerosis.
    Gernert JA; Böhm L; Starck M; Buchka S; Kümpfel T; Kleiter I; Havla J
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosis.
    Zaveri MS; Conger A; Salter A; Frohman TC; Galetta SL; Markowitz CE; Jacobs DA; Cutter GR; Ying GS; Maguire MG; Calabresi PA; Balcer LJ; Frohman EM
    Arch Neurol; 2008 Jul; 65(7):924-8. PubMed ID: 18625859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinal degeneration in primary-progressive multiple sclerosis: A role for cortical lesions?
    Petracca M; Cordano C; Cellerino M; Button J; Krieger S; Vancea R; Ghassemi R; Farrell C; Miller A; Calabresi PA; Lublin F; Inglese M
    Mult Scler; 2017 Jan; 23(1):43-50. PubMed ID: 26993116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive Multiple Sclerosis Is Associated with Faster and Specific Retinal Layer Atrophy.
    Sotirchos ES; Gonzalez Caldito N; Filippatou A; Fitzgerald KC; Murphy OC; Lambe J; Nguyen J; Button J; Ogbuokiri E; Crainiceanu CM; Prince JL; Calabresi PA; Saidha S;
    Ann Neurol; 2020 Jun; 87(6):885-896. PubMed ID: 32285484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High resolution retinal scanning reveals regional structural differences between MS and NMOSD optic neuritis regardless of antibody status.
    Bertsch-Gout M; Loeb R; Finch AK; Javed A; Bernard J
    J Neurol Sci; 2018 Jan; 384():61-66. PubMed ID: 29249380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Innermost Retinal Layers and Visual Evoked Potentials in Patients with Multiple Sclerosis.
    Esen E; Sizmaz S; Balal M; Yar K; Demirkiran M; Unal I; Demircan N
    Curr Eye Res; 2016 Oct; 41(10):1353-1358. PubMed ID: 26882356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripapillary retinal nerve fiber layer thickness measured by optical coherence tomography in different clinical subtypes of multiple sclerosis.
    Jankowska-Lech I; Wasyluk J; Palasik W; Terelak-Borys B; Grabska-Liberek I
    Mult Scler Relat Disord; 2019 Jan; 27():260-268. PubMed ID: 30423530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease course heterogeneity and OCT in multiple sclerosis.
    Balk LJ; Tewarie P; Killestein J; Polman CH; Uitdehaag B; Petzold A
    Mult Scler; 2014 Aug; 20(9):1198-206. PubMed ID: 24402036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantifying visual pathway axonal and myelin loss in multiple sclerosis and neuromyelitis optica.
    Manogaran P; Vavasour IM; Lange AP; Zhao Y; McMullen K; Rauscher A; Carruthers R; Li DKB; Traboulsee AL; Kolind SH
    Neuroimage Clin; 2016; 11():743-750. PubMed ID: 27330974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease-modifying therapies modulate retinal atrophy in multiple sclerosis: A retrospective study.
    Button J; Al-Louzi O; Lang A; Bhargava P; Newsome SD; Frohman T; Balcer LJ; Frohman EM; Prince J; Calabresi PA; Saidha S
    Neurology; 2017 Feb; 88(6):525-532. PubMed ID: 28077493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinal and Optic Nerve Degeneration in Patients with Multiple Sclerosis Followed up for 5 Years.
    Garcia-Martin E; Ara JR; Martin J; Almarcegui C; Dolz I; Vilades E; Gil-Arribas L; Fernandez FJ; Polo V; Larrosa JM; Pablo LE; Satue M
    Ophthalmology; 2017 May; 124(5):688-696. PubMed ID: 28187977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.